T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Hingham Institution for Saving
HIFS
$689M
| $516K | ﹤0.01% |
1,817
+7
| +0.4% | +$2.2K |
|
2202
Cushman & Wakefield Ltd
CWK
$3.24B
| $515K | ﹤0.01% |
33,770
+2,810
| +9% | +$49.4K |
|
|
ADAM
2203
Adamas Trust
ADAM
$913M
| $515K | ﹤0.01% |
46,667
+6,946
| +17% | +$85.1K |
|
2204
C3.ai
AI
$1.58B
| $513K | ﹤0.01% |
28,067
+10,850
| +63% | +$199K |
|
|
LGF.B
2205
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $510K | ﹤0.01% |
57,789
+5,329
| +10% | +$60.7K |
|
|
PR
2206
Permian Resources
PR
$18B
| $507K | ﹤0.01% |
84,730
+2,950
| +4% | +$23.6K |
|
2207
Wabash National
WNC
$507M
| $507K | ﹤0.01% |
37,339
+283
| +0.8% | +$4.08K |
|
2208
Enterprise Financial Services Corp
EFSC
$2.41B
| $505K | ﹤0.01% |
12,160
+2,129
| +21% | +$94.8K |
|
|
LAZR
2209
DELISTED
Luminar Technologies
LAZR
| $505K | ﹤0.01% |
5,672
+2,052
| +57% | +$328K |
|
2210
Center Bancorp
CNOB
$1.81B
| $502K | ﹤0.01% |
20,547
+270
| +1% | +$7.51K |
|
2211
Genesco
GCO
$391M
| $502K | ﹤0.01% |
10,049
-13
| -0.1% | -$779 |
|
2212
Shake Shack
SHAK
$2.94B
| $501K | ﹤0.01% |
12,700
+800
| +7% | +$40.8K |
|
|
WSR
2213
DELISTED
Whitestone REIT
WSR
| $501K | ﹤0.01% |
46,568
+307
| +0.7% | +$3.69K |
|
2214
PJT Partners
PJT
$4.36B
| $498K | ﹤0.01% |
7,090
+230
| +3% | +$16K |
|
|
HSII
2215
DELISTED
Heidrick & Struggles
HSII
| $496K | ﹤0.01% |
15,337
+943
| +7% | +$32.4K |
|
|
UCTT
2216
Ultra Clean Holdings
UCTT
$4.21B
| $496K | ﹤0.01% |
16,646
-1,467
| -8% | -$47.6K |
|
2217
Andersons Inc
ANDE
$2.21B
| $490K | ﹤0.01% |
14,856
+2,092
| +16% | +$89K |
|
|
OSG
2218
Octave Specialty Group
OSG
$210M
| $489K | ﹤0.01% |
43,060
-2,345
| -5% | -$22.3K |
|
2219
Sinclair Inc
SBGI
$1B
| $489K | ﹤0.01% |
23,986
+386
| +2% | +$8.96K |
|
2220
XPeng
XPEV
$11.3B
| $489K | ﹤0.01% |
15,400
| – | – |
|
|
MFA
2221
MFA Financial
MFA
$925M
| $487K | ﹤0.01% |
45,262
-2,224
| -5% | -$30K |
|
|
ATSG
2222
DELISTED
Air Transport Services Group
ATSG
| $487K | ﹤0.01% |
16,965
-2,580
| -13% | -$78.6K |
|
|
SILK
2223
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $485K | ﹤0.01% |
13,319
+295
| +2% | +$10.7K |
|
|
MCBC
2224
DELISTED
Macatawa Bank Corp
MCBC
| $482K | ﹤0.01% |
54,543
+281
| +0.5% | +$2.51K |
|
|
SP
2225
DELISTED
SP Plus Corporation
SP
| $480K | ﹤0.01% |
15,636
+212
| +1% | +$6.4K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.